Walleye Trading
BPMC

Walleye Trading’s Blueprint Medicines BPMC Stock Holding History

Walleye Trading’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,731
Closed -$151K – 4092
2024
Q4 		$151K Buy
+1,731
New +$159K ﹤0.01% 3364
2024
Q1 		– Sell
-21,977
Closed -$1.88M – 4794
2023
Q4 		$2.03M Buy
+21,977
New +$1.42M ﹤0.01% 1916
2023
Q1 		– Sell
-1,094
Closed -$49.3K – 4869
2022
Q4 		$47.9K Buy
+1,094
New +$52.5K ﹤0.01% 4210
2021
Q4 		– Sell
-2,401
Closed -$247K – 5363
2021
Q3 		$247K Buy
+2,401
New +$224K ﹤0.01% 3652
2021
Q1 		– Sell
-560
Closed -$63K – 4819
2020
Q4 		$63K Buy
+560
New +$59K ﹤0.01% 4110
2020
Q2 		– Sell
-31,608
Closed -$1.85M – 4241
2020
Q1 		$1.85M Buy
+31,608
New +$2.03M 0.01% 885
2019
Q3 		– Sell
-758
Closed -$65.5K – 4035
2019
Q2 		$72K Buy
+758
New +$62.6K ﹤0.01% 3424
2018
Q3 		– Sell
-4,511
Closed -$314K – 5285
2018
Q2 		$286K Buy
+4,511
New +$359K ﹤0.01% 3332
2017
Q2 		– Sell
-10,900
Closed -$436 – 4506
2017
Q1 		$436 Buy
+10,900
New +$390K ﹤0.01% 2354
2016
Q3 		– Sell
-1,000
Closed -$20K – 4860
2016
Q2 		$20K Buy
+1,000
New +$18.2K ﹤0.01% 4533

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's BPMC Position: Q1 2025 in Review

Walleye Trading sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 1,731 shares — an estimated $151K sold.

Walleye Trading first reported a position in BPMC in Q2 2016 and held it in 10 quarters. The position peaked at $2.03M in Q4 2023. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.

  • Walleye Trading reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 1,731 Blueprint Medicines shares in Q1 2025, an estimated $151K.
  • Walleye Trading first reported a position in Blueprint Medicines in Q2 2016 and held it in 10 quarters.
  • Walleye Trading's Blueprint Medicines position peaked at $2.03M in Q4 2023.
  • 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.